📰 Continuous Commitment News
Page 2 - Continuous Commitment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Continuous Commitment. Real-time updates on events, politics, business and more.
June 3, 2022
12-month data show that earlier initiation of tofersen slowed decline across measures of clinical and respiratory function, strength, and quality of life…
June 3, 2022
12-month data show that earlier initiation of tofersen slowed decline across measures of clinical and respiratory function, strength, and quality of lifeTofersen also led to robust and sustained reductions
June 3, 2022
12-month data show that earlier initiation of tofersen slowed decline across measures of clinical and respiratory function, strength, and quality of...
March 28, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 28, 2022
BIIB078, an investigational antisense oligonucleotide for C9orf72-associated amyotrophic lateral sclerosis (ALS), did not show clinical benefit; clinical program will be discontinuedBiogen and Ionis remain